← Back to Search

VR Technology for Pupil Disorders (RAPD Trial)

N/A

Waitlist Available

Led By Kevin H Merkley, MD, MBA

Research Sponsored by The University of Texas Medical Branch, Galveston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 - 85

Be older than 18 years old

Must not have

Younger than 18; older than 85 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately following the swinging light test or vr hmd light test

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if an off-the-shelf virtual reality headset and machine learning algorithms can accurately detect a common eye disorder.

Who is the study for?

This trial is for UTMB clinic patients aged 18-85 with known Relative Afferent Pupillary Defect (RAPD) or vision disorders like glaucoma. It's not for those outside this age range, non-English speakers, people uncomfortable with VR devices or glasses, and those with congenital pupil issues.

What is being tested?

Researchers are testing if a virtual reality headset combined with machine learning can detect RAPD more reliably and earlier than the standard swinging flashlight test. Participants will undergo both methods to compare effectiveness.

What are the potential side effects?

There may be discomfort from using the VR head-mounted display, especially for individuals who typically experience discomfort when using glasses or similar devices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 85 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am younger than 18 or older than 85.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately following the swinging light test or vr hmd light test

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately following the swinging light test or vr hmd light test

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately following the swinging light test or vr hmd light test for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Pupillary measurements

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: No Known RAPDExperimental Treatment2 Interventions

Participants with no known RAPD will be administered the standard of care swinging light test and pupil measurements taken manually, then administered the light test using the VR HMD and ML.

Group II: Known RAPDExperimental Treatment2 Interventions

Participants with known RAPD will be administered the standard of care swinging light test and pupil measurements taken manually, then administered the light test using the VR HMD and ML.

0 / 2Eligibility criteria met